✦ LIBER ✦

Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study

✍ Scribed by Manja Reimann, Gunnar Folprecht, Rocco Haase…

Book ID: 120717544
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 310 KB
Volume: 5
Category: Article
ISSN: 2040-7378
DOI: 10.1186/2040-7378-5-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An observational study of plasma vascula

An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer

✍ Brandon P. Verdoorn; Changyong Feng; William A. Ricke; Deepak M. Sahasrabudhe; D 📂 Article 📅 2012 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 113 KB

MC13-0024 Impact of post-progression ant

MC13-0024 Impact of post-progression anti-vascular endothelial growth factor-containing therapy on survival in patients with metastatic colorectal cancer: Data from the PRIME study

✍ Peeters, M.; Douillard, J.Y.; Siena, S.; Price, T.; Tabernero, J.; Sidhu, R.; Br 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Evaluation of a novel blood pressure sco

Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapy

✍ Bilen, Mehmet Asim; Durand, Jean-Bernard; McQuinn, Lacey; Hess, Kenneth R.; Fu, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 187 KB

Cytomegalovirus retinitis after subtenon

Cytomegalovirus retinitis after subtenon triamcinolone acetonide and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus

✍ Noriko Toyokawa; Hideya Kimura; Shinichiro Kuroda 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 226 KB

Safety and efficacy of everolimus in Chi

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

✍ Jun Guo, Yiran Huang, Xu Zhang, Fangjian Zhou, Yinghao Sun, Shukui Qin… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 194 KB

647 POSTER A phase I dose-escalation stu

647 POSTER A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB